Extended therapy in patients with established urinary tract infection.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D002908:Chronic Disease; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000150:complications / Q000188:drug therapy; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011704:Pyelonephritis / Q000150:complications; D013418:Sulfamethazine / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D014556:Urine / Q000382:microbiology
D000892:Anti-Infective Agents, Urinary; D009268:Nalidixic Acid; D013418:Sulfamethazine; D000667:Ampicillin; D009582:Nitrofurantoin